PLoS ONE (Jan 2015)

Proteochemometric modeling of the antigen-antibody interaction: new fingerprints for antigen, antibody and epitope-paratope interaction.

  • Tianyi Qiu,
  • Han Xiao,
  • Qingchen Zhang,
  • Jingxuan Qiu,
  • Yiyan Yang,
  • Dingfeng Wu,
  • Zhiwei Cao,
  • Ruixin Zhu

DOI
https://doi.org/10.1371/journal.pone.0122416
Journal volume & issue
Vol. 10, no. 4
p. e0122416

Abstract

Read online

Despite the high specificity between antigen and antibody binding, similar epitopes can be recognized or cross-neutralized by paratopes of antibody with different binding affinities. How to accurately characterize this slight variation which may or may not change the antigen-antibody binding affinity is a key issue in this area. In this report, by combining cylinder model with shell structure model, a new fingerprint was introduced to describe both the structural and physical-chemical features of the antigen and antibody protein. Furthermore, beside the description of individual protein, the specific epitope-paratope interaction fingerprint (EPIF) was developed to reflect the bond and the environment of the antigen-antibody interface. Finally, Proteochemometric Modeling of the antigen-antibody interaction was established and evaluated on 429 antigen-antibody complexes. By using only protein descriptors, our model achieved the best performance (R2 = 0.91, Qtest(2) = 0.68) among peers. Further, together with EPIF as a new cross-term, our model (R2 = 0.92, Qtest(2) = 0.74) can significantly outperform peers with multiplication of ligand and protein descriptors as a cross-term (R2 ≤ 0.81, Qtest(2) ≤ 0.44). Results illustrated that: 1) our newly designed protein fingerprints and EPIF can better describe the antigen-antibody interaction; 2) EPIF is a better and specific cross-term in Proteochemometric Modeling for antigen-antibody interaction. The fingerprints designed in this study will provide assistance to the description of antigen-antibody binding, and in future, it may be valuable help for the high-throughput antibody screening. The algorithm is freely available on request.